Donor–Recipient Epstein–Barr Virus Serostatus and Time‐Varying Risk of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients
EBV D+/R- recipients experienced highest and sustained 3-year PTLD-risk, while D-/R- recipients faced previously under-recognized early risk. PTLD was strongly linked to mortality and ACGF, refining counselling and supporting targeted surveillance for high-risk groups.
Authors
- Christie Rampersad (ORCID: https://orcid.org/0000-0001-8040-7908)
- S. Joseph Kim
- Seyed M. Hosseini‐Moghaddam
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Toronto General Hospital (CA)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1111/tid.70165
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hennepin Healthcare Research Institute